Seed · Medtech & Devices · Uppsala, Sweden · Founded 2015 · 5–10 employees
Cavis Technologies develops the Wirecath, an innovative pressure guide wire for cardiology that eliminates hydrostatic pressure errors affecting traditional pressure wires. The company has received EU Horizon funding for clinical validation and commercialization. Founded in 2015, they hold 2 patents and have received numerous innovation grants. The Wirecath offers unique precision for assessing coronary artery disease severity and provides superior torque control for navigation in complex anatomies.
No open roles listed right now.